Oscillibacter

Oscillibacter is a genus of Gram-negative, strictly anaerobic, motile bacteria within the family Oscillospiraceae (phylum Firmicutes). The type species, Oscillibacter valericigenes, was first isolated from the alimentary tract of a Japanese freshwater fish and named for its characteristic oscillating motility and its production of valerate (pentanoic acid), a five-carbon short-chain fatty acid that distinguishes it from the more commonly discussed butyrate and propionate producers.

Oscillibacter is ecologically important as a sentinel of heavy metal exposure. Its depletion under cadmium and lead stress has been documented in multiple animal models, positioning it alongside lachnospiraceae family and roseburia as an early casualty of metal-driven dysbiosis.

Metal Dependencies

Oscillibacter depends on iron for its anaerobic metabolism:

  • Iron-sulfur cluster proteins are essential for its electron transport chain and fermentation pathways.
  • This iron dependency makes Oscillibacter vulnerable to toxic metal displacement. Lead exposure (100-500 ppm, 8 weeks) in Balb/C mice significantly decreased Oscillibacter alongside Lachnospiraceae and Ruminococcaceae, with concurrent increases in oxidative stress defense pathways ([1], animal-model).
  • Cadmium exposure in wild long-tailed dwarf hamsters significantly decreased Oscillibacter, identifying it as one of 14 potential pathogens/commensals affected by Cd perturbation ([2], animal-model).

Key Enzymes and Virulence Factors

Oscillibacter is not pathogenic. Its key metabolic enzymes reflect a saccharolytic fermentation strategy:

  • Valerate synthesis enzymes: The genus's defining metabolic feature is production of valerate from carbohydrate fermentation. Valerate has immunomodulatory properties and may influence epithelial differentiation, though it is less studied than butyrate.
  • Butyrate production: Some Oscillibacter species also produce butyrate, contributing to the overall SCFA pool.
  • Bile acid metabolism: Oscillibacter has been implicated in secondary bile acid transformation, linking it to lipid metabolism and cholesterol homeostasis.

Ecological Role

In the healthy gut, Oscillibacter is a moderately abundant member of the Firmicutes community that contributes to the SCFA pool and bile acid metabolism. Its ecological significance becomes apparent under stress:

  • Metal exposure indicator: The reproducible depletion of Oscillibacter under both cadmium and lead exposure makes it a candidate biomarker for environmental metal stress on the gut microbiome.
  • Diet-responsive: On a low-carbohydrate, high-fat (non-ketogenic) diet, Oscillibacter was enriched alongside Escherichia/Shigella, and this LCD-associated community worsened colitis outcomes in mice — contrasting with the ketogenic diet, which enriched beneficial Akkermansia and Roseburia instead ([3], animal-model).
  • Metformin response: Oscillibacter increased in both healthy and T2D subjects after metformin treatment ([4], prospective-cohort).
  • Cancer ecology: In CRC tumor tissue, Oscillibacter abundance correlated with steroid biosynthesis and terpenoid pathways ([5], cross-sectional). After FMT in CRC mice, Oscillibacter was negatively correlated with anti-cancer cytokines, suggesting its reduction may be beneficial in the tumor microenvironment ([6], animal-model).

Conditions Associated

Depleted in:

  • Cadmium exposure: Significantly decreased in wild hamsters exposed to CdCl2, identified among the most affected commensals ([2], animal-model).
  • Lead exposure: Decreased alongside Lachnospiraceae and Ruminococcaceae in lead-exposed mice ([1], animal-model).

Enriched in:

  • Low-carb diet (non-ketogenic): Enriched on LCD but associated with worse colitis outcomes ([3], animal-model).
  • Metformin treatment: Increased in both healthy and T2D subjects after metformin ([4], prospective-cohort).

Complex associations:

  • Colorectal cancer: Tumor tissue associations with steroid/terpenoid metabolism; negatively correlated with anti-cancer cytokines after FMT ([5], cross-sectional; [6], animal-model).

Key Studies

StudyFindingEvidence Level
[2]Significantly depleted by cadmium in wild hamstersAnimal model
[1]Depleted by lead alongside LachnospiraceaeAnimal model
[6]Negatively correlated with anti-cancer cytokines post-FMTAnimal model
[3]Enriched on LCD; worse colitis vs KDAnimal model
[4]Increased by metformin in healthy and T2DProspective cohort

Cross-References

References (13)

  1. Rosenfeld CS (2017). Gut dysbiosis in animals due to environmental chemical exposures. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2017.00396
  2. Mengfan Tao, Kanglin Cao, Xinsheng Pu et al. (2024). Cadmium Exposure Induces Changes in Gut Microbial Composition and Metabolic Function in Long-Tailed Dwarf Hamsters, Cricetulus longicaudatus. Ecology and Evolution. doi:10.1002/ece3.11428
  3. Kong C, Yan X, Liu Y et al. (2021). Ketogenic Diet Alleviates Colitis by Reduction of Colonic Group 3 Innate Lymphoid Cells Through Altering Gut Microbiome. Signal Transduction and Targeted Therapy. doi:10.1038/s41392-021-00549-9
  4. Ilze Elbere, Ivars Silamikelis, Ilze Izabella Dindune et al. (2020). Elbere 2020 — Baseline Gut Microbiome Composition Predicts Metformin Therapy Short-Term Efficacy in Newly Diagnosed Type 2 Diabetes Patients. PLoS ONE. doi:10.1371/journal.pone.0241338
  5. Loke MF, Chua EG, Gan HM et al. (2018). Metabolomics and 16S rRNA Sequencing of Human Colorectal Cancers and Adjacent Mucosa. PLOS ONE. doi:10.1371/journal.pone.0208584
  6. Hao Yu, Xing-Xiu Li, Xing Han et al. (2023). Fecal Microbiota Transplantation Inhibits Colorectal Cancer Progression: Reversing Intestinal Microbial Dysbiosis to Enhance Anti-Cancer Immune Responses. Frontiers in Microbiology
  7. Patrick A. de Jonge, Koen Wortelboer, Torsten P. M. Scheithauer et al. (2022). Gut Virome Profiling Identifies a Widespread Bacteriophage Family Associated with Metabolic Syndrome. Nature Communications. doi:10.1038/s41467-022-31390-5
  8. Gong W, Jin G, Bao Y et al. (2025). Characteristics and potential diagnostic value of gut microbiota in ovarian tumor patients. Scientific Reports. doi:10.1038/s41598-025-99912-x
  9. Quanxin Su, Yanxi Long, Yayin Luo et al. (2023). Su 2023 — Specific Gut Microbiota May Increase the Risk of Erectile Dysfunction (Two-Sample MR). Frontiers in Endocrinology. doi:10.3389/fendo.2023.1216746
  10. Chen et al. (2024). Chen 2024 — Causal Gut Microbiota in Male Erectile Dysfunction (MR). Frontiers in Microbiology. doi:10.3389/fmicb.2024.1367740
  11. Zhang et al. (2023). Zhang 2023 — Causal Gut Microbiota and Erectile Dysfunction (Mendelian Randomization). Frontiers in Microbiology. doi:10.3389/fmicb.2023.1257114
  12. Lyu J, et al. (2024). Lyu 2024 — Care Mode and Gut Microbiota in CP Children. Frontiers in Pediatrics. doi:10.3389/fped.2024.1440190
  13. Congfu Huang, Chunuo Chu, Yuanping Peng et al. (2022). Huang 2022 — Correlations Between Gastrointestinal and Oral Microbiota in Children With Cerebral Palsy and Epilepsy. Frontiers in Pediatrics. doi:10.3389/fped.2022.988601

Related Articles